Novel and Practical Scoring Systems for the Diagnosis of Thyroid Nodules
- PMID: 27654865
- PMCID: PMC5031406
- DOI: 10.1371/journal.pone.0163039
Novel and Practical Scoring Systems for the Diagnosis of Thyroid Nodules
Abstract
Objective: The clinical management of patients with thyroid nodules that are biopsied by fine-needle aspiration cytology and yield indeterminate results remains unsettled. The BRAF V600E mutation has dubious diagnostic value due to its low sensitivity. Novel strategies are urgently needed to distinguish thyroid malignancies from thyroid nodules.
Design: This prospective study included 504 thyroid nodules diagnosed by ultrasonography from 468 patients, and fine-needle aspiration cytology was performed under ultrasound guidance. Cytology and molecular analysis, including BRAF V600E, RET/PTC1 and RET/PTC3, were conducted simultaneously. The cytology, ultrasonography results, and mutational status were gathered and analyzed together. Predictive scoring systems were designed using a combination of diagnostic parameters for ultrasonography, cytology and genetic analysis. The utility of the scoring systems was analyzed and compared to detection using the individual methods alone or combined.
Result: The sensitivity of scoring systema (ultrasonography, cytology, BRAF V600E, RET/PTC) was nearly identical to that of scoring systemb (ultrasonography, cytology, BRAF V600E); these were 91.0% and 90.2%, respectively. These sensitivities were significantly higher than those obtained using FNAC, genetic analysis and US alone or combined; their sensitivities were 63.9%, 70.7% and 87.2%, respectively. Scoring systemc (ultrasonography, cytology) was slightly inferior to the former two scoring systems but still had relatively high sensitivity and specificity (80.5% and 95.1%, respectively), which were significantly superior to those of single cytology, ultrasonography or genetic analysis. In nodules with uncertainty cytology, scoring systema, scoring systemb and scoring systemc could elevate the malignancy detection rates to 69.7%, 69.7% and 63.6%, respectively.
Conclusion: These three scoring systems were quick for clinicians to master and could provide quantified information to predict the probability of malignant nodules. Scoring systemb is recommended for improving the detection rate among nodules of uncertain cytology.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.Pathol Res Pract. 2015 Sep;211(9):671-6. doi: 10.1016/j.prp.2015.06.010. Epub 2015 Jul 2. Pathol Res Pract. 2015. PMID: 26187369
-
BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles.AJR Am J Roentgenol. 2012 Mar;198(3):668-74. doi: 10.2214/AJR.11.7185. AJR Am J Roentgenol. 2012. PMID: 22358007
-
BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.Thyroid. 2010 Mar;20(3):273-9. doi: 10.1089/thy.2009.0226. Thyroid. 2010. PMID: 20187782
-
What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.Surgery. 2015 Feb;157(2):354-61. doi: 10.1016/j.surg.2014.09.003. Surgery. 2015. PMID: 25616949
-
Integrated Diagnostics of Thyroid Nodules.Cancers (Basel). 2024 Jan 11;16(2):311. doi: 10.3390/cancers16020311. Cancers (Basel). 2024. PMID: 38254799 Free PMC article. Review.
Cited by
-
Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.Thyroid. 2019 Nov;29(11):1594-1605. doi: 10.1089/thy.2019.0278. Epub 2019 Sep 27. Thyroid. 2019. PMID: 31469053 Free PMC article.
-
BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.Cancer Med. 2022 Jan;11(1):40-49. doi: 10.1002/cam4.4419. Epub 2021 Dec 1. Cancer Med. 2022. PMID: 34851044 Free PMC article.
References
-
- Rabaglia JL, Kabbani W, Wallace L, Holt S, Watumull L, Pruitt J, et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery. 2010;148(6):1267–72; discussion 72–3. 10.1016/j.surg.2010.09.017 . - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials